Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer

Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer, With Focus on Background Parenchymal Enhancement

The aim of this retrospective study is to evaluate the value of pre-treatment and post-treatment multimodality MRI study, including quantitative evaluation of background parenchymal enhancement, for response prediction and evaluation. This study will include 100 patients treated in a single institution between 2011 and 2016

Inclusion Criteria:

• Adult patients
• Patients with breast cancer treated with neoadjuvant chemotherapy
• Patients with pre- and post-chemotherapy MRI
• Patients who have given their agreement to use their data for research purposes.

Exclusion Criteria:

- Refusal to participate in the study